Effect Of Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors on Body Mass Index After 3 Months of Use in Diabetic Patients

NCT07367555 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

360

Enrollment

OTHER

Sponsor class

Conditions

Diabete Mellitus

Interventions

DRUG: Oral 100 gram Empagliflozin tablet along with diet plan and exercise
OTHER: Diet plan and exercise

Sponsor

Ariba Shafiq